Welcome! It's great that you're doing your research before starting treatment β that's a really smart move. Moving from watch and wait to an active treatment plan can feel like a big step, but knowing what to expect can make it a little less daunting.
Your doctor has recommended a combination approach. Here's a quick Show Full Answer
Welcome! It's great that you're doing your research before starting treatment β that's a really smart move. Moving from watch and wait to an active treatment plan can feel like a big step, but knowing what to expect can make it a little less daunting.
Your doctor has recommended a combination approach. Here's a quick breakdown of each:
- Acalabrutinib (Calquence) β An oral pill that blocks a protein called BTK, which leukemia cells need to grow and survive
- Venetoclax (Venclexta) β Another oral pill that blocks a protein called BCL-2, making it easier for leukemia cells to die
- Obinutuzumab (Gazyva) β An injection (infusion) that targets a protein on leukemia cells called CD20, helping your immune system find and destroy them Together, these three work as a team to attack leukemia from different angles, which tends to be more effective than any single drug alone.
Like all treatments, there are some side effects to be aware of, including:
- Neutropenia (low white blood cell count, which can raise infection risk)
- Headache
- Diarrhea
- Muscle and bone pain
- Increased risk of infections
- Possible bleeding
Venetoclax also carries a warning for something called tumor lysis syndrome β a rare but serious reaction that can happen when many cancer cells break down very quickly. Your care team will monitor you closely for this, especially early on. The good news is that clinical trial data on the acalabrutinib and venetoclax combination showed a 35% reduction in the risk of the cancer getting worse or death compared to standard chemotherapy. That's an encouraging sign for this type of treatment approach.
Always make sure to ask your doctor about any concerns before starting β no question is too small. Wishing you all the best as you begin this next chapter! π
October 13